What’s Going On With Vanda Pharma Stock Tuesday?

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) stock rose Tuesday following the FDA’s recent approval of Bysanti, a new oral treatment for bipolar I disorder and schizophrenia. FDA Approves Bysanti, Boosting Vanda’s Portfolio The FDA’s approval of Bysanti marks a pivotal...